Table 4.
Cox Regression Analysis for Overall Survival in the CRC Subset with Stage I and II Tumors
| Clinical parameters | Univariate |
Multivariate |
||
|---|---|---|---|---|
| Risk ratio (95% CI) | P value | Risk ratio (95% CI) | P value | |
| Age ≥50 years | 1.17 (0.80 –1.74) | 0.4306 | 1.37 (0.36 –6.62) | 0.6550 |
| Male sex | 1.10 (0.76 –1.59) | 0.6084 | 1.32 (0.41 –4.47) | 0.6379 |
| Grade 3 tumor (poorly differentiated) | 1.41 (0.90 –2.14) | 0.1307 | 0.78 (0.04 –4.77) | 0.8199 |
| MSI-S/L (stable/low) | 2.04 (1.14 –4.05) | 0.0149 | 2.78 (0.51 –52.0) | 0.2770 |
| UBE2C overexpression | 3.35 (1.13 –11.1) | 0.0291 | 3.67 (1.15 –14.03) | 0.0276 |
CI, confidence interval; MSI, microsatellite instability status; S/L, stable/low [ie, not MSI-H (high)].